Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda

You are here

Franceschi et al, International Journal of Cancer, 2016 (Publication)

Aim: To assess the feasibility of first-void urine as a sample type to measure the impact of vaccination against Human Papilloma Virus (HPV) in Rwanda and Bhutan

Partners: WHO-IARC, University of Antwerp (VAXINFECTIO), Novosanis nv

Results: This  study supports the feasibility of urine surveys to monitor HPV vaccination and quantifies the effectiveness of the quadrivalent vaccine in women vaccinated after pre-adolescence.